Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.36p
   
  • Change Today:
    -0.15p
  • 52 Week High: 3.35
  • 52 Week Low: 0.85
  • Currency: UK Pounds
  • Shares Issued: 416.44m
  • Volume: 2,030,895
  • Market Cap: £9.81m
  • RiskGrade: 328

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £35,053
Lisa Baderoon 583,963 £13,752
Tim Franklin 525,000 £12,364

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 54,111,858 £1,274,334
Luca & Associates AG 22,000,000 £518,100
Invesco Ltd 17,872,341 £420,894
Aviva Investors Global 11,285,180 £265,766
Alora Pharmaceuticals LLC 10,909,091 £256,909
M&G Investments 7,600,000 £178,980
Prudential plc 7,600,000 £178,980
Capital Income Builder 4,870,367 £114,697
Dr R Zimmer 4,551,553 £107,189
Odey Asset Management 3,433,319 £80,855
Rhone Trustees (Switzerland) SA 3,386,000 £79,740
Pictet Overseas Trust Corporation Limited 3,287,500 £77,421

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 2.36p
Change Today -0.15p
% Change -5.80 %
52 Week High 3.35
52 Week Low 0.85
Volume 2,030,895
Shares Issued 416.44m
Market Cap £9.81m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
73.91% below the market average73.91% below the market average73.91% below the market average73.91% below the market average73.91% below the market average
37.25% below the sector average37.25% below the sector average37.25% below the sector average37.25% below the sector average37.25% below the sector average
Price Trend
17.77% below the market average17.77% below the market average17.77% below the market average17.77% below the market average17.77% below the market average
24.53% above the sector average24.53% above the sector average24.53% above the sector average24.53% above the sector average24.53% above the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 11-Jun-2024

Time Volume / Share Price
16:20 10,483 @ 2.42p
16:20 82,430 @ 2.42p
16:20 90,010 @ 2.42p
16:20 1,500 @ 2.32p
15:34 397 @ 2.32p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page